A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
Clinical trial NCT04538794 · COMPLETED
Trial details
- NCT number
- NCT04538794
- Sponsor
- Celldex Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2023-01-17
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.